20-23 October 2009
Boston, US

Americas largest Phase I strategy congress

Exploratory Clinical Development World Americas attracts record numbers of early clinical development scientists and decision makers to explore the challenges of phase I trials. It addresses the critical issues in achieving seamless first-in-man studies and also provides advice on how to conduct effective clinical studies that facilitate making the right decisions early on in exploratory clinical development.

Find answers to your early clinical development questions:

• How should we be developing drugs in the 21st century?
• What is the role of clinical pharmacology in providing solutions?
• What are the operational and ethical issues in using patients in phase I clinical trials? 
• What is the role and use of model based drug development and can this reduce uncertainty? 
• What is the potential of microdosing and what can this offer in exploratory development? 
• How can biomarkers be used in early development decision making? 
• What are the regulatory, procedural, and statistical considerations in Thorough QT Studies?  
• What is the potential of adaptive trial designs?

Who will attend?

Senior Directors and Heads of Department working in Research & Development, Clinical Research, Clinical Pharmacology, Phase I Trials, Exploratory Development, Clinical Trials, Regulatory Affairs, PK / PD and Clinical Operations.

Location: Hyatt Regency, Boston, United States

www.healthnetworkcommunications.com/2009/explorusa

pairving@healthnetworkcommunications.com

+44 (0)207 608 7055